Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan

Biochimica et Biophysica Acta - General Subjects

Volumn 1861, Issue 10, 2017, Pages 2462-2472

  Manya, Hiroshi ^a   Endo, Tamao ^a  

^a Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

Glycan biosynthesis; Glycosyltransferase; Muscular dystrophy; O glycosylation; O mannosyl glycan; Ribitol 5 phosphate; dystroglycanopathy

Indexed keywords

GLYCAN DERIVATIVE; N ACETYLGLUCOSAMINYLTRANSFERASE; O MANNOSYL GLYCA; PHOSPHATE; POMGNT1 PROTEIN; RIBITOL; RIBITOL 5 PHOSPHATE; UNCLASSIFIED DRUG; DAG1 PROTEIN, HUMAN; DYSTROGLYCAN; MANNOSE; PENTOSE PHOSPHATE; POLYSACCHARIDE; PROTEIN O-MANNOSE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; RIBITOL-5-PHOSPHATE;

ALPHA DYSTROGLYCANOPATHY; BRAIN DISEASE; BRAIN FUNCTION; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; CHEMICAL MODIFICATION; DISEASE COURSE; ENZYME ACTIVITY; GENE FUNCTION; GENE MUTATION; GENETIC DISORDER; GLYCOSYLATION; HOMEOSTASIS; HUMAN; MAMMAL; MOLECULAR BIOLOGY; MOLECULAR PATHOLOGY; MUSCLE FUNCTION; NONHUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; REVIEW; STRUCTURE ANALYSIS; ANIMAL; BRAIN; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR MODEL; MUSCULAR DYSTROPHY; PATHOLOGY; PROTEIN PROCESSING; SKELETAL MUSCLE; WALKER WARBURG SYNDROME;

ANIMALS; BRAIN; CARBOHYDRATE SEQUENCE; DYSTROGLYCANS; GLYCOSYLATION; HUMANS; MANNOSE; MODELS, MOLECULAR; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; N-ACETYLGLUCOSAMINYLTRANSFERASES; PENTOSEPHOSPHATES; POLYSACCHARIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; WALKER-WARBURG SYNDROME;

EID: 85024926832     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2017.06.024     Document Type: Review

References (94)

1. Chiba, A., Matsumura, K., Yamada, H., Inazu, T., Shimizu, T., Kusunoki, S., Kanazawa, I., Kobata, A., Endo, T., Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J. Biol. Chem. 272 (1997), 2156–2162.
2. Endo, T., Glycobiology of alpha-dystroglycan and muscular dystrophy. J. Biochem. 157 (2015), 1–12.
3. Manya, H., Endo, T., O-mannosyl glycan and muscular dystrophy. Suzuki, T., Ohtsubo, K., Taniguchi, N., (eds.) Sugar Chains: Decoding the Functions of Glycans, 2015, Springer Japan, Tokyo, 235–258.
4. Yuen, C.T., Chai, W., Loveless, R.W., Lawson, A.M., Margolis, R.U., Feizi, T., Brain contains HNK-1 immunoreactive O-glycans of the sulfoglucuronyl lactosamine series that terminate in 2-linked or 2,6-linked hexose (mannose). J. Biol. Chem. 272 (1997), 8924–8931.
5. Sasaki, T., Yamada, H., Matsumura, K., Shimizu, T., Kobata, A., Endo, T., Detection of O-mannosyl glycans in rabbit skeletal muscle alpha-dystroglycan. Biochim. Biophys. Acta 1425 (1998), 599–606.
6. Yoshida, A., Kobayashi, K., Manya, H., Taniguchi, K., Kano, H., Mizuno, M., Inazu, T., Mitsuhashi, H., Takahashi, S., Takeuchi, M., Herrmann, R., Straub, V., Talim, B., Voit, T., Topaloglu, H., Toda, T., Endo, T., Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell 1 (2001), 717–724.
7. Manya, H., Chiba, A., Yoshida, A., Wang, X., Chiba, Y., Jigami, Y., Margolis, R.U., Endo, T., Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 500–505.
8. Beltran-Valero De Bernabe, D., Currier, S., Steinbrecher, A., Celli, J., Van Beusekom, E., Van Der Zwaag, B., Kayserili, H., Merlini, L., Chitayat, D., Dobyns, W.B., Cormand, B., Lehesjoki, A.E., Cruces, J., Voit, T., Walsh, C.A., Van Bokhoven, H., Brunner, H.G., Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am. J. Hum. Genet. 71 (2002), 1033–1043.
9. Manya, H., Sakai, K., Kobayashi, K., Taniguchi, K., Kawakita, M., Toda, T., Endo, T., Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease. Biochem. Biophys. Res. Commun. 306 (2003), 93–97.
10. van Reeuwijk, J., Janssen, M., van den Elzen, C., Beltran-Valero de Bernabe, D., Sabatelli, P., Merlini, L., Boon, M., Scheffer, H., Brockington, M., Muntoni, F., Huynen, M.A., Verrips, A., Walsh, C.A., Barth, P.G., Brunner, H.G., van Bokhoven, H., POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J. Med. Genet. 42 (2005), 907–912.
11. Manya, H., Bouchet, C., Yanagisawa, A., Vuillaumier-Barrot, S., Quijano-Roy, S., Suzuki, Y., Maugenre, S., Richard, P., Inazu, T., Merlini, L., Romero, N.B., Leturcq, F., Bezier, I., Topaloglu, H., Estournet, B., Seta, N., Endo, T., Guicheney, P., Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies. Neuromuscul. Disord. 18 (2008), 45–51.
12. Muntoni, F., Brockington, M., Blake, D.J., Torelli, S., Brown, S.C., Defective glycosylation in muscular dystrophy. Lancet 360 (2002), 1419–1421.
13. Michele, D.E., Campbell, K.P., Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J. Biol. Chem. 278 (2003), 15457–15460.
14. Brancaccio, A., Schulthess, T., Gesemann, M., Engel, J., Electron microscopic evidence for a mucin-like region in chick muscle alpha-dystroglycan. FEBS Lett. 368 (1995), 139–142.
15. Yamada, H., Chiba, A., Endo, T., Kobata, A., Anderson, L.V., Hori, H., Fukuta-Ohi, H., Kanazawa, I., Campbell, K.P., Shimizu, T., Matsumura, K., Characterization of dystroglycan-laminin interaction in peripheral nerve. J. Neurochem. 66 (1996), 1518–1524.
16. Brancaccio, A., Schulthess, T., Gesemann, M., Engel, J., The N-terminal region of alpha-dystroglycan is an autonomous globular domain. Eur. J. Biochem. 246 (1997), 166–172.
17. Kanagawa, M., Saito, F., Kunz, S., Yoshida-Moriguchi, T., Barresi, R., Kobayashi, Y.M., Muschler, J., Dumanski, J.P., Michele, D.E., Oldstone, M.B., Campbell, K.P., Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell 117 (2004), 953–964.
18. Kanagawa, M., Kobayashi, K., Tajiri, M., Manya, H., Kuga, A., Yamaguchi, Y., Akasaka-Manya, K., Furukawa, J., Mizuno, M., Kawakami, H., Shinohara, Y., Wada, Y., Endo, T., Toda, T., Identification of a post-translational modification with Ribitol-phosphate and its defect in muscular dystrophy. Cell Rep. 14 (2016), 2209–2223.
19. Manya, H., Yamaguchi, Y., Kanagawa, M., Kobayashi, K., Tajiri, M., Akasaka-Manya, K., Kawakami, H., Mizuno, M., Wada, Y., Toda, T., Endo, T., The muscular dystrophy gene TMEM5 encodes a ribitol beta1-4 Xylosyltransferase required for the functional glycosylation of dystroglycan. J. Biol. Chem. 161 (2016), 99–111.
20. Kuwabara, N., Manya, H., Yamada, T., Tateno, H., Kanagawa, M., Kobayashi, K., Akasaka-Manya, K., Hirose, Y., Mizuno, M., Ikeguchi, M., Toda, T., Hirabayashi, J., Senda, T., Endo, T., Kato, R., Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of alpha-dystroglycan. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 9280–9285.
21. Inamori, K., Endo, T., Ide, Y., Fujii, S., Gu, J., Honke, K., Taniguchi, N., Molecular cloning and characterization of human GnT-IX, a novel beta1,6-N-acetylglucosaminyltransferase that is specifically expressed in the brain. J. Biol. Chem. 278 (2003), 43102–43109.
22. Kaneko, M., Alvarez-Manilla, G., Kamar, M., Lee, I., Lee, J.K., Troupe, K., Zhang, W., Osawa, M., Pierce, M., A novel beta(1,6)-N-acetylglucosaminyltransferase V (GnT-VB)(1). FEBS Lett. 554 (2003), 515–519.
23. Inamori, K., Endo, T., Gu, J., Matsuo, I., Ito, Y., Fujii, S., Iwasaki, H., Narimatsu, H., Miyoshi, E., Honke, K., Taniguchi, N., N-Acetylglucosaminyltransferase IX acts on the GlcNAc beta 1,2-Man alpha 1-Ser/Thr moiety, forming a 2,6-branched structure in brain O-mannosyl glycan. J. Biol. Chem. 279 (2004), 2337–2340.
24. Yoshida-Moriguchi, T., Yu, L., Stalnaker, S.H., Davis, S., Kunz, S., Madson, M., Oldstone, M.B., Schachter, H., Wells, L., Campbell, K.P., O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science 327 (2010), 88–92.
25. Lommel, M., Winterhalter, P.R., Willer, T., Dahlhoff, M., Schneider, M.R., Bartels, M.F., Renner-Muller, I., Ruppert, T., Wolf, E., Strahl, S., Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 21024–21029.
26. Vester-Christensen, M.B., Halim, A., Joshi, H.J., Steentoft, C., Bennett, E.P., Levery, S.B., Vakhrushev, S.Y., Clausen, H., Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 21018–21023.
27. Takahashi, S., Sasaki, T., Manya, H., Chiba, Y., Yoshida, A., Mizuno, M., Ishida, H., Ito, F., Inazu, T., Kotani, N., Takasaki, S., Takeuchi, M., Endo, T., A new beta-1,2-N-acetylglucosaminyltransferase that may play a role in the biosynthesis of mammalian O-mannosyl glycans. Glycobiology 11 (2001), 37–45.
28. Kanekiyo, K., Inamori, K., Kitazume, S., Sato, K., Maeda, J., Higuchi, M., Kizuka, Y., Korekane, H., Matsuo, I., Honke, K., Taniguchi, N., Loss of branched O-mannosyl glycans in astrocytes accelerates remyelination. J. Neurosci. 33 (2013), 10037–10047.
29. Morise, J., Kizuka, Y., Yabuno, K., Tonoyama, Y., Hashii, N., Kawasaki, N., Manya, H., Miyagoe-Suzuki, Y., Takeda, S., Endo, T., Maeda, N., Takematsu, H., Oka, S., Structural and biochemical characterization of O-mannose-linked human natural killer-1 glycan expressed on phosphacan in developing mouse brains. Glycobiology 24 (2014), 314–324.
30. Yaji, S., Manya, H., Nakagawa, N., Takematsu, H., Endo, T., Kannagi, R., Yoshihara, T., Asano, M., Oka, S., Major glycan structure underlying expression of the Lewis X epitope in the developing brain is O-mannose-linked glycans on phosphacan/RPTPbeta. Glycobiology 25 (2015), 376–385.
31. Bleckmann, C., Geyer, H., Lieberoth, A., Splittstoesser, F., Liu, Y., Feizi, T., Schachner, M., Kleene, R., Reinhold, V., Geyer, R., O-glycosylation pattern of CD24 from mouse brain. Biol. Chem. 390 (2009), 627–645.
32. Dwyer, C.A., Baker, E., Hu, H., Matthews, R.T., RPTPzeta/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1. Neuroscience 220 (2012), 47–61.
33. Pacharra, S., Hanisch, F.G., Breloy, I., Neurofascin 186 is O-mannosylated within and outside of the mucin domain. J. Proteome Res. 11 (2012), 3955–3964.
34. Pacharra, S., Hanisch, F.G., Muhlenhoff, M., Faissner, A., Rauch, U., Breloy, I., The lecticans of mammalian brain perineural net are O-mannosylated. J. Proteome Res. 12 (2013), 1764–1771.
35. Lee, J.K., Matthews, R.T., Lim, J.M., Swanier, K., Wells, L., Pierce, J.M., Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V. J. Biol. Chem. 287 (2012), 28526–28536.
36. Yagi, H., Kuo, C.W., Obayashi, T., Ninagawa, S., Khoo, K.H., Kato, K., Direct mapping of additional modifications on phosphorylated O-glycans of alpha-dystroglycan by mass spectrometry analysis in conjunction with knocking out of causative genes for dystroglycanopathy. Mol. Cell. Proteomics 15 (2016), 3424–3434.
37. Gerin, I., Ury, B., Breloy, I., Bouchet-Seraphin, C., Bolsee, J., Halbout, M., Graff, J., Vertommen, D., Muccioli, G.G., Seta, N., Cuisset, J.M., Dabaj, I., Quijano-Roy, S., Grahn, A., Van Schaftingen, E., Bommer, G.T., ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto alpha-dystroglycan. Nat. Commun., 7, 2016, 11534.
38. Praissman, J.L., Willer, T., Sheikh, M.O., Toi, A., Chitayat, D., Lin, Y.Y., Lee, H., Stalnaker, S.H., Wang, S., Prabhakar, P.K., Nelson, S.F., Stemple, D.L., Moore, S.A., Moremen, K.W., Campbell, K.P., Wells, L., The functional O-mannose glycan on alpha-dystroglycan contains a phospho-ribitol primed for matriglycan addition. elife, 5, 2016, e14473.
39. Ervasti, J.M., Campbell, K.P., A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122 (1993), 809–823.
40. Bowe, M.A., Deyst, K.A., Leszyk, J.D., Fallon, J.R., Identification and purification of an agrin receptor from Torpedo postsynaptic membranes: a heteromeric complex related to the dystroglycans. Neuron 12 (1994), 1173–1180.
41. Gee, S.H., Montanaro, F., Lindenbaum, M.H., Carbonetto, S., Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 77 (1994), 675–686.
42. Peng, H.B., Ali, A.A., Daggett, D.F., Rauvala, H., Hassell, J.R., Smalheiser, N.R., The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Cell Adhes. Commun. 5 (1998), 475–489.
43. Talts, J.F., Andac, Z., Gohring, W., Brancaccio, A., Timpl, R., Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J. 18 (1999), 863–870.
44. Sugita, S., Saito, F., Tang, J., Satz, J., Campbell, K., Sudhof, T.C., A stoichiometric complex of neurexins and dystroglycan in brain. J. Cell Biol. 154 (2001), 435–445.
45. Sato, S., Omori, Y., Katoh, K., Kondo, M., Kanagawa, M., Miyata, K., Funabiki, K., Koyasu, T., Kajimura, N., Miyoshi, T., Sawai, H., Kobayashi, K., Tani, A., Toda, T., Usukura, J., Tano, Y., Fujikado, T., Furukawa, T., Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. Nat. Neurosci. 11 (2008), 923–931.
46. Wright, K.M., Lyon, K.A., Leung, H., Leahy, D.J., Ma, L., Ginty, D.D., Dystroglycan organizes axon guidance cue localization and axonal pathfinding. Neuron 76 (2012), 931–944.
47. Michele, D.E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R.D., Satz, J.S., Dollar, J., Nishino, I., Kelley, R.I., Somer, H., Straub, V., Mathews, K.D., Moore, S.A., Campbell, K.P., Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418 (2002), 417–422.
48. Moore, S.A., Saito, F., Chen, J., Michele, D.E., Henry, M.D., Messing, A., Cohn, R.D., Ross-Barta, S.E., Westra, S., Williamson, R.A., Hoshi, T., Campbell, K.P., Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418 (2002), 422–425.
49. Endo, T., Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies. Acta Myol. 24 (2005), 64–69.
50. Briggs, D.C., Yoshida-Moriguchi, T., Zheng, T., Venzke, D., Anderson, M.E., Strazzulli, A., Moracci, M., Yu, L., Hohenester, E., Campbell, K.P., Structural basis of laminin binding to the LARGE glycans on dystroglycan. Nat. Chem. Biol. 12 (2016), 810–814.
51. Manya, H., Akasaka-Manya, K., Nakajima, A., Kawakita, M., Endo, T., Role of N-glycans in maintaining the activity of protein O-mannosyltransferases POMT1 and POMT2. J. Biochem. 147 (2010), 337–344.
52. Manya, H., Suzuki, T., Akasaka-Manya, K., Ishida, H.K., Mizuno, M., Suzuki, Y., Inazu, T., Dohmae, N., Endo, T., Regulation of mammalian protein O-mannosylation: preferential amino acid sequence for O-mannose modification. J. Biol. Chem. 282 (2007), 20200–20206.
53. Akasaka-Manya, K., Manya, H., Nakajima, A., Kawakita, M., Endo, T., Physical and functional association of human protein O-mannosyltransferases 1 and 2. J. Biol. Chem. 281 (2006), 19339–19345.
54. Akasaka-Manya, K., Manya, H., Hayashi, M., Endo, T., Different roles of the two components of human protein O-mannosyltransferase, POMT1 and POMT2. Biochem. Biophys. Res. Commun. 411 (2011), 721–725.
55. Carss, K.J., Stevens, E., Foley, A.R., Cirak, S., Riemersma, M., Torelli, S., Hoischen, A., Willer, T., van Scherpenzeel, M., Moore, S.A., Messina, S., Bertini, E., Bonnemann, C.G., Abdenur, J.E., Grosmann, C.M., Kesari, A., Punetha, J., Quinlivan, R., Waddell, L.B., Young, H.K., Wraige, E., Yau, S., Brodd, L., Feng, L., Sewry, C., MacArthur, D.G., North, K.N., Hoffman, E., Stemple, D.L., Hurles, M.E., van Bokhoven, H., Campbell, K.P., Lefeber, D.J., Lin, Y.Y., Muntoni, F., Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of alpha-dystroglycan. Am. J. Hum. Genet. 93 (2013), 29–41.
56. Lefeber, D.J., de Brouwer, A.P., Morava, E., Riemersma, M., Schuurs-Hoeijmakers, J.H., Absmanner, B., Verrijp, K., van den Akker, W.M., Huijben, K., Steenbergen, G., van Reeuwijk, J., Jozwiak, A., Zucker, N., Lorber, A., Lammens, M., Knopf, C., van Bokhoven, H., Grunewald, S., Lehle, L., Kapusta, L., Mandel, H., Wevers, R.A., Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylation. PLoS Genet., 7, 2011, e1002427.
57. Maeda, Y., Tanaka, S., Hino, J., Kangawa, K., Kinoshita, T., Human dolichol-phosphate-mannose synthase consists of three subunits, DPM1, DPM2 and DPM3. EMBO J. 19 (2000), 2475–2482.
58. Lefeber, D.J., Schonberger, J., Morava, E., Guillard, M., Huyben, K.M., Verrijp, K., Grafakou, O., Evangeliou, A., Preijers, F.W., Manta, P., Yildiz, J., Grunewald, S., Spilioti, M., van den Elzen, C., Klein, D., Hess, D., Ashida, H., Hofsteenge, J., Maeda, Y., van den Heuvel, L., Lammens, M., Lehle, L., Wevers, R.A., Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies. Am. J. Hum. Genet. 85 (2009), 76–86.
59. Barone, R., Aiello, C., Race, V., Morava, E., Foulquier, F., Riemersma, M., Passarelli, C., Concolino, D., Carella, M., Santorelli, F., Vleugels, W., Mercuri, E., Garozzo, D., Sturiale, L., Messina, S., Jaeken, J., Fiumara, A., Wevers, R.A., Bertini, E., Matthijs, G., Lefeber, D.J., DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy. Ann. Neurol. 72 (2012), 550–558.
60. Yang, A.C., Ng, B.G., Moore, S.A., Rush, J., Waechter, C.J., Raymond, K.M., Willer, T., Campbell, K.P., Freeze, H.H., Mehta, L., Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy. Mol. Genet. Metab. 110 (2013), 345–351.
61. Bakker, H., Friedmann, I., Oka, S., Kawasaki, T., Nifant'ev, N., Schachner, M., Mantei, N., Expression cloning of a cDNA encoding a sulfotransferase involved in the biosynthesis of the HNK-1 carbohydrate epitope. J. Biol. Chem. 272 (1997), 29942–29946.
62. Terayama, K., Oka, S., Seiki, T., Miki, Y., Nakamura, A., Kozutsumi, Y., Takio, K., Kawasaki, T., Cloning and functional expression of a novel glucuronyltransferase involved in the biosynthesis of the carbohydrate epitope HNK-1. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 6093–6098.
63. Kaneko, M., Kudo, T., Iwasaki, H., Ikehara, Y., Nishihara, S., Nakagawa, S., Sasaki, K., Shiina, T., Inoko, H., Saitou, N., Narimatsu, H., Alpha1,3-fucosyltransferase IX (Fuc-TIX) is very highly conserved between human and mouse; molecular cloning, characterization and tissue distribution of human Fuc-TIX. FEBS Lett. 452 (1999), 237–242.
64. Seiki, T., Oka, S., Terayama, K., Imiya, K., Kawasaki, T., Molecular cloning and expression of a second glucuronyltransferase involved in the biosynthesis of the HNK-1 carbohydrate epitope. Biochem. Biophys. Res. Commun. 255 (1999), 182–187.
65. Sasaki, N., Manya, H., Okubo, R., Kobayashi, K., Ishida, H., Toda, T., Endo, T., Nishihara, S., beta4GalT-II is a key regulator of glycosylation of the proteins involved in neuronal development. Biochem. Biophys. Res. Commun. 333 (2005), 131–137.
66. Kudo, T., Fujii, T., Ikegami, S., Inokuchi, K., Takayama, Y., Ikehara, Y., Nishihara, S., Togayachi, A., Takahashi, S., Tachibana, K., Yuasa, S., Narimatsu, H., Mice lacking alpha1,3-fucosyltransferase IX demonstrate disappearance of Lewis x structure in brain and increased anxiety-like behaviors. Glycobiology 17 (2007), 1–9.
67. Nakagawa, N., Manya, H., Toda, T., Endo, T., Oka, S., Human natural killer-1 sulfotransferase (HNK-1ST)-induced sulfate transfer regulates laminin-binding glycans on alpha-dystroglycan. J. Biol. Chem. 287 (2012), 30823–30832.
68. Yoshida-Moriguchi, T., Willer, T., Anderson, M.E., Venzke, D., Whyte, T., Muntoni, F., Lee, H., Nelson, S.F., Yu, L., Campbell, K.P., SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function. Science 341 (2013), 896–899.
69. Halmo, S.M., Singh, D., Patel, S., Wang, S., Edlin, M., Boons, G.J., Moremen, K.W., Live, D., Wells, L., Protein O-linked mannose beta-1,4-N-Acetylglucosaminyl-transferase 2 (POMGNT2) is a gatekeeper enzyme for functional glycosylation of alpha-Dystroglycan. J. Biol. Chem. 292 (2017), 2101–2109.
70. Praissman, J.L., Live, D.H., Wang, S., Ramiah, A., Chinoy, Z.S., Boons, G.J., Moremen, K.W., Wells, L., B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of alpha-dystroglycan. elife, 3, 2014, e03943.
71. Willer, T., Inamori, K., Venzke, D., Harvey, C., Morgensen, G., Hara, Y., Beltran Valero de Bernabe, D., Yu, L., Wright, K.M., Campbell, K.P., The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated alpha-dystroglycan functional glycosylation. elife, 3, 2014, e03941.
72. Inamori, K., Yoshida-Moriguchi, T., Hara, Y., Anderson, M.E., Yu, L., Campbell, K.P., Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science 335 (2012), 93–96.
73. Ashikov, A., Buettner, F.F., Tiemann, B., Gerardy-Schahn, R., Bakker, H., LARGE2 generates the same xylose- and glucuronic acid-containing glycan structures as LARGE. Glycobiology 23 (2013), 303–309.
74. Inamori, K., Hara, Y., Willer, T., Anderson, M.E., Zhu, Z., Yoshida-Moriguchi, T., Campbell, K.P., Xylosyl- and glucuronyltransferase functions of LARGE in alpha-dystroglycan modification are conserved in LARGE2. Glycobiology 23 (2013), 295–302.
75. Inamori, K.I., Beedle, A.M., de Bernabe, D.B., Wright, M.E., Campbell, K.P., LARGE2-dependent glycosylation confers laminin-binding ability on proteoglycans. Glycobiology 26 (2016), 1284–1296.
76. Hara, Y., Kanagawa, M., Kunz, S., Yoshida-Moriguchi, T., Satz, J.S., Kobayashi, Y.M., Zhu, Z., Burden, S.J., Oldstone, M.B., Campbell, K.P., Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 17426–17431.
77. Hara, Y., Balci-Hayta, B., Yoshida-Moriguchi, T., Kanagawa, M., Beltran-Valero de Bernabe, D., Gundesli, H., Willer, T., Satz, J.S., Crawford, R.W., Burden, S.J., Kunz, S., Oldstone, M.B., Accardi, A., Talim, B., Muntoni, F., Topaloglu, H., Dincer, P., Campbell, K.P., A dystroglycan mutation associated with limb-girdle muscular dystrophy. N. Engl. J. Med. 364 (2011), 939–946.
78. Brown, S., Santa Maria, J.P. Jr., Walker, S., Wall teichoic acids of gram-positive bacteria. Annu. Rev. Microbiol. 67 (2013), 313–336.
79. Roscioli, T., Kamsteeg, E.J., Buysse, K., Maystadt, I., van Reeuwijk, J., van den Elzen, C., van Beusekom, E., Riemersma, M., Pfundt, R., Vissers, L.E., Schraders, M., Altunoglu, U., Buckley, M.F., Brunner, H.G., Grisart, B., Zhou, H., Veltman, J.A., Gilissen, C., Mancini, G.M., Delree, P., Willemsen, M.A., Ramadza, D.P., Chitayat, D., Bennett, C., Sheridan, E., Peeters, E.A., Tan-Sindhunata, G.M., de Die-Smulders, C.E., Devriendt, K., Kayserili, H., El-Hashash, O.A., Stemple, D.L., Lefeber, D.J., Lin, Y.Y., van Bokhoven, H., Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of alpha-dystroglycan. Nat. Genet. 44 (2012), 581–585.
80. Willer, T., Lee, H., Lommel, M., Yoshida-Moriguchi, T., de Bernabe, D.B., Venzke, D., Cirak, S., Schachter, H., Vajsar, J., Voit, T., Muntoni, F., Loder, A.S., Dobyns, W.B., Winder, T.L., Strahl, S., Mathews, K.D., Nelson, S.F., Moore, S.A., Campbell, K.P., ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat. Genet. 44 (2012), 575–580.
81. Riemersma, M., Froese, D.S., van Tol, W., Engelke, U.F., Kopec, J., van Scherpenzeel, M., Ashikov, A., Krojer, T., von Delft, F., Tessari, M., Buczkowska, A., Swiezewska, E., Jae, L.T., Brummelkamp, T.R., Manya, H., Endo, T., van Bokhoven, H., Yue, W.W., Lefeber, D.J., Human ISPD is a Cytidyltransferase required for Dystroglycan O-Mannosylation. Chem. Biol. 22 (2015), 1643–1652.
82. Kobayashi, K., Nakahori, Y., Miyake, M., Matsumura, K., Kondo-Iida, E., Nomura, Y., Segawa, M., Yoshioka, M., Saito, K., Osawa, M., Hamano, K., Sakakihara, Y., Nonaka, I., Nakagome, Y., Kanazawa, I., Nakamura, Y., Tokunaga, K., Toda, T., An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394 (1998), 388–392.
83. Brockington, M., Blake, D.J., Prandini, P., Brown, S.C., Torelli, S., Benson, M.A., Ponting, C.P., Estournet, B., Romero, N.B., Mercuri, E., Voit, T., Sewry, C.A., Guicheney, P., Muntoni, F., Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am. J. Hum. Genet. 69 (2001), 1198–1209.
84. Brockington, M., Yuva, Y., Prandini, P., Brown, S.C., Torelli, S., Benson, M.A., Herrmann, R., Anderson, L.V., Bashir, R., Burgunder, J.M., Fallet, S., Romero, N., Fardeau, M., Straub, V., Storey, G., Pollitt, C., Richard, I., Sewry, C.A., Bushby, K., Voit, T., Blake, D.J., Muntoni, F., Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum. Mol. Genet. 10 (2001), 2851–2859.
85. Kano, H., Kobayashi, K., Herrmann, R., Tachikawa, M., Manya, H., Nishino, I., Nonaka, I., Straub, V., Talim, B., Voit, T., Topaloglu, H., Endo, T., Yoshikawa, H., Toda, T., Deficiency of alpha-dystroglycan in muscle-eye-brain disease. Biochem. Biophys. Res. Commun. 291 (2002), 1283–1286.
86. Akasaka-Manya, K., Manya, H., Kobayashi, K., Toda, T., Endo, T., Structure-function analysis of human protein O-linked mannose b1,2-N-acetylglucosaminyltransferase 1, POMGnT1. Biochem. Biophys. Res. Commun. 320 (2004), 39–44.
87. Xiong, H., Kobayashi, K., Tachikawa, M., Manya, H., Takeda, S., Chiyonobu, T., Fujikake, N., Wang, F., Nishimoto, A., Morris, G.E., Nagai, Y., Kanagawa, M., Endo, T., Toda, T., Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of alpha-dystroglycan. Biochem. Biophys. Res. Commun. 350 (2006), 935–941.
88. Xu, M., Yamada, T., Sun, Z., Eblimit, A., Lopez, I., Wang, F., Manya, H., Xu, S., Zhao, L., Li, Y., Kimchi, A., Sharon, D., Sui, R., Endo, T., Koenekoop, R.K., Chen, R., Mutations in POMGNT1 cause non-syndromic retinitis pigmentosa. Hum. Mol. Genet. 25 (2016), 1479–1488.
89. Grewal, P.K., Holzfeind, P.J., Bittner, R.E., Hewitt, J.E., Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Nat. Genet. 28 (2001), 151–154.
90. Liu, J., Ball, S.L., Yang, Y., Mei, P., Zhang, L., Shi, H., Kaminski, H.J., Lemmon, V.P., Hu, H., A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1). Mech. Dev. 123 (2006), 228–240.
91. Abbott, K.L., Matthews, R.T., Pierce, M., Receptor tyrosine phosphatase beta (RPTPbeta) activity and signaling are attenuated by glycosylation and subsequent cell surface galectin-1 binding. J. Biol. Chem. 283 (2008), 33026–33035.
92. Morita, I., Kakuda, S., Takeuchi, Y., Itoh, S., Kawasaki, N., Kizuka, Y., Kawasaki, T., Oka, S., HNK-1 glyco-epitope regulates the stability of the glutamate receptor subunit GluR2 on the neuronal cell surface. J. Biol. Chem. 284 (2009), 30209–30217.
93. Morita, I., Kakuda, S., Takeuchi, Y., Kawasaki, T., Oka, S., HNK-1 (human natural killer-1) glyco-epitope is essential for normal spine morphogenesis in developing hippocampal neurons. Neuroscience 164 (2009), 1685–1694.
94. Hennen, E., Czopka, T., Faissner, A., Structurally distinct LewisX glycans distinguish subpopulations of neural stem/progenitor cells. J. Biol. Chem. 286 (2011), 16321–16331.